Researchers at the Medical University of South Carolina reveal a novel binding site for a class of anti-cancer drugs known as E1 inhibitors. This finding could lead to the design of more efficient E1 inhibitors.
Original Article: MUSC researchers discover new mechanism for a class of anti-cancer drugs